Melanoma drug side effects on eyes revealed in new study
NCT ID NCT07431489
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examined 30 people with melanoma who were taking BRAF/MEK inhibitor drugs to see how often these drugs cause retinal changes (MEKAR) and what those changes look like. Participants had regular eye exams before, during, and after treatment. The goal was to better understand and track these eye side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can two immune boosters beat advanced melanoma?
- Drug duo takes on rare head and neck tumors
- Experimental cancer therapy targets tough tumors with radioactive precision
- Keytruda immune response trial aims to unlock cancer clues
- Experimental combo aims to supercharge cancer immunotherapy
- AI-Designed mRNA vaccine takes on advanced tumors in first human test